Adar Poonawalla, the CEO of Serum Institute of India (SII), the world’s most voluminous producer of vaccines, has said that SII would be collaborating with the transgender activist – Laxmi Narayan Tripathi, to ensure that the community is vaccinated.
“I have always believed that healthcare and dignity should be fundamental human rights. I look forward to collaborate with @ImLaxmiNarayan in providing equal opportunities to the transgender community in India,” tweeted Adar Poonawalla, on 12th July, 2021. Up until June 2021, only 11.45% of the transgender population was partially vaccinated with one dose of the Covid-19 vaccine.
SII manufactures the Covishield vaccine, under licence from AstraZeneca, and is also preparing to use a local version of the Novavax vaccine. Most of the vaccines used in India are Covishield.
- એક ટૂંકી વાર્તા - 21 December2024
- હસો મારી સાથે - 21 December2024
- વૃધ્ધાવસ્થાનો સાચો આધાર!! - 21 December2024
